<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11</volume><submitter>Bouisset F</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>The long-term impact of type 2 diabetes mellitus (T2DM) after an acute myocardial infarction (AMI) has not been thoroughly investigated yet. This study aimed to assess the long-term impact of T2DM after AMI.&lt;h4>Research design and methods&lt;/h4>We analyzed the data of three nationwide observational studies from the French Registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction (FAST-MI) program, conducted over a 1-month period in 2005, 2010, and 2015. Patients presenting T2DM were classified as diabetic, and patients presenting type 1 diabetes mellitus were excluded. We identified factors related to all-cause death at 1-year follow-up and divided 1,897 subjects into two groups, paired based on their estimated 1-year probability of death as determined by a </pubmed_abstract><journal>Frontiers in cardiovascular medicine</journal><pagination>1401569</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11204119</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Type 2 diabetes mellitus in acute myocardial infarction: a persistent significant burden on long-term mortality.</pubmed_title><pmcid>PMC11204119</pmcid><pubmed_authors>Ferrieres J</pubmed_authors><pubmed_authors>Bouisset F</pubmed_authors><pubmed_authors>Schiele F</pubmed_authors><pubmed_authors>Puymirat E</pubmed_authors><pubmed_authors>Fayol A</pubmed_authors><pubmed_authors>Simon T</pubmed_authors><pubmed_authors>Bataille V</pubmed_authors><pubmed_authors>Danchin N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Type 2 diabetes mellitus in acute myocardial infarction: a persistent significant burden on long-term mortality.</name><description>&lt;h4>Objective&lt;/h4>The long-term impact of type 2 diabetes mellitus (T2DM) after an acute myocardial infarction (AMI) has not been thoroughly investigated yet. This study aimed to assess the long-term impact of T2DM after AMI.&lt;h4>Research design and methods&lt;/h4>We analyzed the data of three nationwide observational studies from the French Registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction (FAST-MI) program, conducted over a 1-month period in 2005, 2010, and 2015. Patients presenting T2DM were classified as diabetic, and patients presenting type 1 diabetes mellitus were excluded. We identified factors related to all-cause death at 1-year follow-up and divided 1,897 subjects into two groups, paired based on their estimated 1-year probability of death as determined by a </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024</publication><modification>2025-06-01T01:39:54.91Z</modification><creation>2025-06-01T01:39:54.91Z</creation></dates><accession>S-EPMC11204119</accession><cross_references><pubmed>38932992</pubmed><doi>10.3389/fcvm.2024.1401569</doi></cross_references></HashMap>